HCMSG - Hepatitis C Mentor & Support Group, Inc.
Search
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
  • Resources
    • Corona Virus
    • Hep C Facts & Stats
    • Medications and Treatments >
      • Patient Assistance Programs
    • Reading
    • Links
  • Programs/Training
    • The Circle Model >
      • THE CIRCLE Registration
      • Group and Facilitator Guide
    • Hepatitis C Online Training
    • The Hepatitis C Education and Support Group Assistance Program
    • Healthcare Provider Training
  • Newsletter
  • Blog
  • Support Us
    • Holiday 2020
  • Contact Us

What We Talk About When We Talk About Hepatitis C

9/19/2015

0 Comments

 
by Lucinda Porter,R.N. Posted: 09/17/2015 5:55 pm EDT Updated: 09/17/2015 5:59 pm EDT THE BLOG
Since 2007, more people have died every year from hepatitis C than from HIV. Fortunately, the latest hepatitis C medications can cure nearly everyone in a relatively quick, easy fashion. So, if it is so easy to cure hepatitis C, why haven't we?

Ostensibly, it is because of the cost. At $1125 a pill for Gilead Sciences' drug Harvoni, a 12-week course of hepatitis C treatment would amount to $94,500. Trying to manage these costs, many state Medicaid programs and insurance companies have severely restricted access to treatment. You save money if you deny treatment to people, and dead people cost nothing.

This means that although we can cure hepatitis C, we aren't. Under many insurance plans, patients have to prove that they have cirrhosis. In short, treatment is approved when liver damage has progressed to its worst stage. It is like refusing to pay for diabetes drugs until the patient is blind or minus a few toes.

In addition to proof of cirrhosis, insurers create hurdles that require mountains of paperwork and patience. Some require documentation that patients have abstained from alcohol and drugs for six months to a year prior to treatment. If substance use is recent, patients must be actively participating in treatment for the disorder. This practice is not required for cancer or diabetes patients. Imagine if your doctor said to you, "We can cure your cancer, but your insurance won't pay for treatment because marijuana showed up on your tox screen."

There are other hurdles. For instance, Illinois's Medicaid plan has 17 bulleted requirements, including a "commitment to care" document to be signed by the patient. Alaska's Medicaid program has invented its own hurdle that is not medically approved. The hep C drugs will not be renewed if a patient's response doesn't meet these arbitrary standards, despite the fact that the HCV treatment guidelines set by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America do not recommend stopping treatment for this reason. But, insurers are not following these evidence-based guidelines, since if they did, they'd have to treat just about every hepatitis C patient, which is what the guidelines recommend.

The fear is that if everyone were treated, then the cost would be astronomical. However, the cost of treatment is not really the issue. What we are really talking about when we talk about hep C is prejudice. Hepatitis C's association with drug use makes it easy to discriminate against those who have this disease. Health plans can get away with their arbitrary restrictions, because the public isn't particularly sympathetic to hepatitis C patients. Ask Jane or John Q. Public how people get hep C, and I bet they say it's from drug use, a problem which is highly stigmatized.

I am familiar with the stigma attached to this virus. Although now cured, I was hep C-positive for 25 years. I was open about my status, and most people assumed that I got hepatitis C through my work as a nurse, thus sparing me from the harsh criticism drug users often get. However, occasionally I endured cruel judgments from critics who assumed that I was an injection drug user, and thus I deserved hepatitis C.

It is common to hear fellow hep C patients complain about being treated like injection drug users. The tragedy is not that hep C-positive people are lumped together with drug users. The tragedy is that it is socially acceptable to condemn and ostracize drug users. Private and public insurers participate in this social ostracism by restricting access to treatment, hurting the poor and minorities the most with these unjust practices.

Treatment restrictions ignore the fact that those with hepatitis C are at increased risk of premature death from multiple medical problems, including, lymphoma, cerebrovascular conditions, cancer, and kidney diseases. On average, hep C patientsdie around 15 years earlier than those who aren't infected. Hepatitis C is a risk factor for liver cancer, which has the second highest mortality rate, just behind pancreatic.

How do we explain these restrictive policies to a young woman with minimal liver damage, but wants to be free of hep C prior to starting a family? Do we tell her, "Take a chance, maybe your baby won't get hepatitis C. We can always treat you and your baby when you each develop cirrhosis."

Access to hepatitis C treatment affects everyone. If we ration health care for this disease, it is just a matter of time before we ration coverage for other diseases. Paraphrasing Martin Niemöller's famous words, "First, they denied treatment for hepatitis C, and I did not speak out because I did not have hepatitis C." How many more people have to be infected or die from hep C before we speak up? Or, do we have to wait until we restrict medical coverage for all diseases, and perhaps lose a few toes before we protest.


http://www.huffingtonpost.com/lucinda-porter/what-we-talk-about-when-we-talk-about-hepatitis-c_b_7984878.html

Follow Lucinda Porter on Twitter: www.twitter.com/LucindaPorterRN

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011

    Categories

    All

    RSS Feed

Privacy Policy